home / stock / pfnx / pfnx news

PFNX News and Press, Pfenex Inc. From 10/07/19

Stock Information
Company Name: Pfenex Inc.
Stock Symbol: PFNX
Market: NYSE
Website: pfenex.com
Menu
PFNX PFNX Quote PFNX Short PFNX News PFNX Articles PFNX Message Board
Get PFNX Alerts

News, Short Squeeze, Breakout and More Instantly...
PFNX - FDA OKs Pfenex Forteo biosimilar; shares up 9% premarket

Under its 505(b)(2) pathway, the FDA approves Pfenex's (NYSEMKT: PFNX ) PF708, a biosimilar to Eli Lilly's (NYSE: LLY ) osteoporosis med Forteo (teriparatide injection), for certain patients at high risk of fracture. More news on: Pfenex Inc., Eli Lilly and Company, Healthcare stocks new...
PFNX - Pfenex Receives U.S. FDA Approval for PF708 to Treat Osteoporosis

Pfenex earns a $2.5M milestone payment from Alvogen for U.S. approval Comparative human factors study report expected to be submitted to FDA as early as the second half of October 2019 SAN DIEGO, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) announced today th...

PFNX - Microcaps mostly among midday movers

Gainers:  electroCore (NASDAQ: ECOR ) +43% . Avaya Holdings (NYSE: AVYA ) +26% . RingCentral (NYSE: RNG ) +26% . Exela Technologies (NASDAQ: XELA ) +23% . YRC Worldwide (NASDAQ: YRCW ) +17% . Zosano Pharma Corporation (NASDAQ: ZSAN ) +16% . BroadVision (NASDAQ: BVSN ) +16% . Ch...

PFNX - Pfenex to Present at the Cantor Healthcare Conference

SAN DIEGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to improve protein therapies for unmet patient needs, today announced that Ee...
PFNX - Pfenex to Participate in the Oppenheimer Fall Summit

SAN DIEGO, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to improve protein therapies for unmet patient needs, today announced that Ee...

PFNX - Pfenex Earns $11 Million Development Milestone under its Development and License Agreement with Jazz Pharmaceuticals

SAN DIEGO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) today announced that it has earned an $11 million development milestone under its development and license agreement with Jazz Pharmaceuticals. The milestone is associated with process development activities for ...

PFNX - Pfenex Appoints Dr. Steve Kay to Scientific Advisory Board

SAN DIEGO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to improve protein therapies for unmet patient needs, today announced the app...
PFNX - Pfenex's (PFNX) CEO Eef Schimmelpennink on Q2 2019 Results - Earnings Call Transcript

Pfenex Inc. (PFNX) Q2 2019 Results Conference Call August 8, 2019 4:30 PM ET Company Participants Eef Schimmelpennink – President and Chief Executive Officer Susan Knudson – Chief Financial Officer Conference Call Participants Andy Hsieh – William Blair ...

PFNX - Pfenex EPS beats by $0.07, misses on revenue

Pfenex (NYSEMKT: PFNX ): Q2 GAAP EPS of -$0.24 beats by $0.07 . More news on: Pfenex Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

PFNX - Pfenex Announces Appointment of New Board Member, Lorianne Masuoka, M.D.

SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to improve protein therapies for unmet patient needs, today announced the appo...
Previous 10 Next 10